We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

161 hedge funds and large institutions have $815M invested in Meridian Bioscience Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 66 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less capital invested

Capital invested by funds: $851M → $815M (-$36M)

3% less funds holding

Funds holding: 166161 (-5)

17% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 23

23% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 66

71% less call options, than puts

Call options by funds: $469K | Put options by funds: $1.62M

Holders
161
Holders Change
-5
Holders Change %
-3.01%
% of All Funds
4.63%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
51
Reduced
66
Closed
23
Calls
$469K
Puts
$1.62M
Net Calls
-$1.15M
Net Calls Change
-$1.08M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$5.11M +$5.09M +247,727 New
KCM
27
Kornitzer Capital Management
Kansas
$4.92M -$863K -42,000 -15%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$4.78M +$37.3K +1,814 +0.8%
CAI
29
Capital Advisors Inc
Oklahoma
$4.75M +$751K +36,539 +19%
PP
30
Prudential plc
United Kingdom
$4.66M +$4.64M +225,900 New
Deutsche Bank
31
Deutsche Bank
Germany
$4.13M -$1.52M -74,132 -27%
MAA
32
Managed Account Advisors
New Jersey
$3.49M -$250K -12,148 -7%
TCIM
33
TIAA CREF Investment Management
New York
$3.34M -$15.5K -753 -0.5%
PAM
34
Panagora Asset Management
Massachusetts
$3.16M -$1.84M -89,302 -37%
New York State Teachers Retirement System (NYSTRS)
35
New York State Teachers Retirement System (NYSTRS)
New York
$3.03M -$2.06K -100 -0.1%
Charles Schwab
36
Charles Schwab
California
$2.95M +$144K +7,002 +5%
BIM
37
BlackRock Investment Management
Delaware
$2.82M -$19.1K -931 -0.7%
GF
38
Gabelli Funds
New York
$2.79M +$925K +45,000 +50%
Wells Fargo
39
Wells Fargo
California
$2.78M +$485K +23,599 +21%
ACM
40
American Capital Management
New York
$2.73M
GI
41
GAMCO Investors
Connecticut
$2.68M +$781K +38,000 +41%
TA
42
Teton Advisors
New York
$2.58M +$616K +30,000 +32%
NFA
43
Nationwide Fund Advisors
Ohio
$2.53M -$304K -14,787 -11%
Invesco
44
Invesco
Georgia
$2.47M -$385K -18,725 -14%
Millennium Management
45
Millennium Management
New York
$2.41M +$1.46M +70,993 +155%
CIS
46
Connors Investor Services
Pennsylvania
$2.24M -$1.87K -91 -0.1%
BFO
47
Boston Family Office
Massachusetts
$2.13M -$19.1K -931 -0.9%
Goldman Sachs
48
Goldman Sachs
New York
$2.13M +$318K +15,482 +18%
KAM
49
Keeley Asset Management
Illinois
$2.12M -$105K -5,100 -5%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$2.05M -$37K -1,800 -2%

VIVO Hedge Fund Activity: Q2 2014 in Review

161 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2014, worth a combined $815M — down 4.2% from $851M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VIVO and 19 opened new positions — a net loss of 4 holders — while 66 trimmed existing stakes and 51 added.

The largest buyer was Perkins Investment Management, adding an estimated $8.51M. The largest seller was Cincinnati Insurance, exiting entirely with an estimated $15.9M sold.

  • 161 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2014, down from 166 in Q1 2014.
  • Funds reported $815M of Meridian Bioscience Inc stock for Q2 2014, down 4.2% quarter-over-quarter.
  • 19 funds opened new Meridian Bioscience Inc positions in Q2 2014 and 23 closed out, a net change of -4 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2014 was Perkins Investment Management, an estimated $8.51M added.
  • The largest Meridian Bioscience Inc seller in Q2 2014 was Cincinnati Insurance, an estimated $15.9M sold.

Based on aggregated 13F filings for Q2 2014.